The Global Point-of-Care or Rapid Diagnostics market had reached xxx million USD with a CAGR xx from 2015-2019. Later on, it will go to xxx million USD in 2020 with a CAGR xx % from 2020 to 2025.
In the global Point-of-Care or Rapid Diagnostics market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the market on the basis of application, type, regions, and manufactures.
In market segmentation by manufacturers, the report covers the following companies- Roche
Abbott
Johnson & Johnson
Siemens Healthcare
Danaher
Ascensia
Bio-Rad Laboratories
BioMerieux
ARKRAY
Nova Biomedical
Trividia Health
Quidel
Accriva
OraSure Technologies
Helena Laboratories
A. Menarini Diagnostics
Abaxis (Zoetis)
Ortho Clinical Diagnostics
Phamatech
Chembio Diagnostics
Sinocare
Wondfo
Yuwell
Runbio
KHB
Wuhan EasyDiagnosis Biomedicine
DAAN GENE
In market segmentation by geographical regions, the report has analysed the following regions-
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In market segmentation by types :
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Urinalysis Testing
Others
In market segmentation by applications :
Clinics
Hospitals
Laboratory
Others
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Point-of-Care or Rapid Diagnostics market for the forecast period 2020 - 2025?
• What are the driving forces in the Point-of-Care or Rapid Diagnostics market for the forecast period 2020 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Point-of-Care or Rapid Diagnostics industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?